SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
夺命大猩猩
Lv1
30 积分
2024-03-22 加入
最近求助
最近应助
互助留言
FXR agonists for MASH therapy: Lessons and perspectives from obeticholic acid
3天前
已完结
Comparison of Wild-Type and High-risk PNPLA3 variants in a Human Biomimetic Liver Microphysiology System for Metabolic Dysfunction-associated Steatotic Liver Disease Precision Therapy
3天前
已完结
PharmVar GeneFocus: SLCO1B1
10天前
已完结
Effect of CYP2C9 and SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of nateglinide in healthy Chinese male volunteers
10天前
已完结
An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH
11天前
已完结
Opportunities and challenges following approval of resmetirom for MASH liver disease
16天前
已完结
The first MASH drug therapy on the horizon: Current perspectives of resmetirom
1个月前
已完结
Resmetirom proves positive for NASH with liver fibrosis
1个月前
已完结
Resmetirom, the first approved drug for the management of metabolic dysfunction-associated steatohepatitis: Trials, opportunities, and challenges
1个月前
已完结
Resmetirom for NASH: balancing promise and prudence
1个月前
已完结
没有进行任何应助
没有进行任何互助留言
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论